Extension of DG ESIC Ayurvedic Rate Contract No. Ay.-9 · U-16013/141/2022-AYUSH-Part (2)

File No. U-16013/141/2022-AYUSH-Part (2) Date: 16.02.2026 To, The Deans - All PGIMSR / ESIC Medical College & Hospitals The Medical Superintendent – All ESIC Hospitals The Director (Medical) Delhi/Noida The Director, ESI Scheme –All States Regional Director - All States Subject: Extension of DG ESIC Rate Contract No. Ay. 9 issued vide No. U- 15/13/6/ Ayur.-9/2022-AYUSH, dated 17.11.2023 Madam/Sir, I am hereby directed to inform the approval of Director General ESIC for extension of existing DG ESIC Rate Contract No. Ay.9 w.e.f 17.01.2026 to 16.06.2026 (earlier extended from 17.11.2025 to 16.01.2026) or till the finalization of the new Rate Contract, whichever is earlier subject to the following terms & conditions: 1.Willingness of the firm to supply on the same terms and conditions as approved in rate contract No. Ay.9. 2.No order should be placed in respect of drugs, which have been found "Not of Standard Quality" on test analysis. 3.Supply order should be placed only to first preference holders. 4.Amendments /orders (if any) already issued time to time in r/o items /firms of Rate Contract No. Ay.9 to be taken into consideration while placing the supply orders. The list of L-1 drugs approved under DG ESIC Rate Contract no. Ay.-9 is attached for your information and further necessary action. This is for your kind information and further necessary action. This is issued with approval of the Competent Authority. Yours sincerely,

(Dr. Pawan Kumar) DMC (AYUSH) Copy to:

• PPS / PS to DG, FC, MC (Ayush) U-16013/141/2022-AYUSH-Part(2) I/3590791/2026

• Account Branch V, ESIC Hqrs Office

• Zonal Medical Commissioners (North, South, East, West, North East)

• Website Content Manager for uploading on ESIC website

• Guard File U-16013/141/2022-AYUSH-Part(2) I/3590791/2026